Search

Fibralign Corporation Appoints Dimitris Dionysiou, Ph.D., M.D. as Chief Medical Officer

Fibralign Corporation, a developer of advanced therapeutic medical devices, announces the appointment of Dimitris Dionysiou, Ph.D., M.D. as its Chief Medical Officer. Dr. Dionysiou joins the Company during the clinical phase for its first product, the BioBridge® Collagen Matrix where it will be evaluated for its effectiveness for treating secondary lymphedema. ​ Dr. Dionyssiou is a renowned plastic and reconstructive microsurgeon who is internationally recognized for his research and clinical work in breast reconstruction and surgical treatments for lymphedema. Dr. Dionysiou joins Fibralign from Aristotle University of Thessaloniki (Greece) where he serves as Assistant Professor in Plast

WHO WE ARE

Fibralign Corporation is a developer of advanced therapeutic devices that utilizes Nanoweave ®, a proprietary scaffolding technology for addressing unmet medical needs.

Read More >

QUICK LINKS
GET IN TOUCH